U.S. Trade Agreement Talks On Drug Pricing Shift To G-8 Nations
This article was originally published in The Pink Sheet Daily
Executive Summary
Administration’s focus "is primarily on the G-8 countries" following a bilateral agreement with Australia that increases transparency in drug reimbursement determinations, U.S. Trade Rep. Zoellick tells Senate Finance Committee.
You may also be interested in...
Medicare Part B Reimbursement Covered By U.S.-Australia Trade Pact
Medicare Part D and Medicaid are excluded from Free Trade Agreement drug provisions, as are VA and DoD drug purchases, U.S. Trade Representative says. FTA does not prevent Congress from passing drug importation legislation.
Medicare Part B Reimbursement Covered By U.S.-Australia Trade Pact
Medicare Part D and Medicaid are excluded from Free Trade Agreement drug provisions, as are VA and DoD drug purchases, U.S. Trade Representative says. FTA does not prevent Congress from passing drug importation legislation.
International Rx Price Study To Be Used In Negotiations With Developed Countries
Study mandated by Medicare Rx law could be used to convince developed countries of the need to reduce price controls, Commerce Department official tells Senate subcommittees.